• LAST PRICE
    0.9443
  • TODAY'S CHANGE (%)
    Trending Up0.0321 (3.5190%)
  • Bid / Lots
    0.9413/ 1
  • Ask / Lots
    0.9476/ 6
  • Open / Previous Close
    0.9300 / 0.9122
  • Day Range
    Low 0.9109
    High 0.9566
  • 52 Week Range
    Low 0.8354
    High 1.9300
  • Volume
    505,321
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.9122
TimeVolumePGEN
09:32 ET28470.93
09:34 ET16000.9122
09:36 ET51080.9109
09:38 ET29910.9147
09:39 ET25790.9189
09:41 ET41360.93
09:43 ET64840.9274
09:45 ET2000.9274
09:50 ET69100.9272
09:52 ET13280.9274
09:56 ET14870.9298
09:57 ET7000.928
10:06 ET18970.9231
10:08 ET2000.9299
10:10 ET34810.93
10:12 ET12770.938
10:14 ET15000.9299
10:15 ET10080.9254
10:17 ET54810.9343
10:19 ET1000.9318
10:21 ET6000.93235
10:24 ET8000.9343
10:26 ET4000.9343
10:28 ET2000.933
10:32 ET14250.938
10:33 ET13130.938
10:35 ET93450.9374
10:37 ET3000.9374
10:39 ET2670.9372
10:42 ET122520.9385
10:44 ET30350.9398
10:46 ET130290.9423
10:48 ET3000.9491
10:50 ET6030.9404
10:51 ET4000.9491
10:53 ET7210.9491
10:55 ET21620.9455
10:57 ET11140.9389
11:00 ET8000.942
11:02 ET7000.9442
11:04 ET6090.9447
11:06 ET9000.9455
11:08 ET2000.946
11:09 ET2000.9468
11:11 ET60580.94655
11:13 ET5000.9461
11:15 ET10360.947
11:18 ET16810.9486
11:20 ET6220.94791
11:22 ET16160.9465
11:24 ET1000.9468
11:26 ET23230.94585
11:27 ET4000.9474
11:29 ET12510.9453
11:31 ET67210.9419
11:33 ET4550.9473
11:36 ET1230.9487
11:40 ET7030.9487
11:42 ET20000.945551
11:47 ET4270.94555
11:51 ET1000.943
11:56 ET13830.9431
12:00 ET21000.94515
12:02 ET22560.9463
12:05 ET27030.9463
12:07 ET1140.9461
12:09 ET41500.9431
12:12 ET67630.943
12:16 ET24000.9384
12:18 ET2000.9369
12:21 ET35000.938137
12:23 ET26670.938599
12:30 ET1000.9343
12:38 ET1000.9363
12:45 ET4380.9368
12:48 ET8120.93725
12:50 ET1000.9375
12:52 ET8000.9385
12:54 ET1000.9387
12:56 ET158880.9486
12:57 ET20000.947
12:59 ET20000.948599
01:01 ET3000.9487
01:06 ET2000.9486
01:08 ET456670.9482
01:10 ET67700.9482
01:12 ET27000.9457
01:14 ET1000.9434
01:17 ET2000.9434
01:19 ET1170.9433
01:21 ET4500.9431
01:24 ET31180.9452
01:26 ET304300.9461
01:33 ET4000.9485
01:35 ET179690.955
01:37 ET5000.95275
01:39 ET5000.9533
01:44 ET33870.9521
01:46 ET60940.9496
01:48 ET49800.95
01:51 ET420700.9555
01:53 ET206800.95275
01:55 ET5000.95425
01:57 ET3000.95425
02:02 ET20980.9517
02:06 ET3090.9505
02:08 ET18000.95
02:11 ET14000.94835
02:15 ET2000.9483
02:18 ET2000.9464
02:20 ET4020.9463
02:22 ET20690.9475
02:24 ET120000.9463
02:26 ET13000.9448
02:29 ET11390.9441
02:31 ET104340.9442
02:33 ET15000.943199
02:36 ET1000.94
02:38 ET20000.94
02:40 ET158980.9416
02:44 ET258240.9518
02:45 ET13660.9474
02:47 ET14060.9485
02:51 ET1000.9457
02:54 ET10000.9499
02:56 ET13040.9462
02:58 ET25000.9424
03:00 ET69860.9454
03:02 ET90950.946901
03:03 ET10540.94845
03:05 ET1250.946931
03:07 ET56050.946306
03:09 ET20000.9443
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPGEN
Precigen Inc
260.5M
-1.7x
---
United StatesSCPH
scPharmaceuticals Inc
221.1M
-3.0x
---
United StatesASPI
ASP Isotopes Inc
194.7M
-4.3x
---
United StatesTELO
Telomir Pharmaceuticals Inc
191.3M
-9.9x
---
United StatesHCIL
Hongchang International Co Ltd
140.1M
-450.0x
---
United StatesGBLP
Global Pharmatech Inc
138.3M
-3.6x
---
As of 2024-09-27

Company Information

Precigen, Inc. is a dedicated discovery and clinical-stage biopharmaceutical company advancing gene and cell therapies. The Company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. Exemplar segment is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar (Exemplar), its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Contact Information

Headquarters
20374 SENECA MEADOWS PARKWAYGERMANTOWN, MD, United States 20876
Phone
301-556-9900
Fax
---

Executives

Executive Chairman of the Board
Randal Kirk
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
Helen Sabzevari
Chief Financial Officer
Harry Thomasian
Chief Operating Officer
Rutul Shah
Senior Vice President - Intellectual Property Affairs
Jeffrey Perez

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$260.5M
Revenue (TTM)
$4.4M
Shares Outstanding
285.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.66
EPS
$-0.54
Book Value
$0.48
P/E Ratio
-1.7x
Price/Sales (TTM)
59.3
Price/Cash Flow (TTM)
---
Operating Margin
-3,199.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.